Related Experiment Videos
Case management within a methadone maintenance program. A research demonstration project for HIV risk reduction
Summary
Case management in methadone maintenance treatment may not reduce human immunodeficiency virus (HIV) risk in heroin addicts. Implementation barriers include patient participation issues and provider reluctance, hindering widespread adoption.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Substance Abuse Treatment
Background:
- Heroin addiction is a significant public health issue associated with high-risk behaviors.
- Human immunodeficiency virus (HIV) transmission is a major concern within populations of intravenous drug users.
- Methadone maintenance treatment is a cornerstone for managing opioid dependence.
Purpose of the Study:
- To evaluate the effectiveness of case management in reducing HIV risk among high-risk heroin addicts.
- To assess the impact of enhanced services on HIV infection and transmission rates.
- To identify challenges in the large-scale implementation of case management within methadone programs.
Main Methods:
- Randomized controlled trial comparing enhanced case management to standard methadone maintenance.
- Recruitment of high-risk heroin addicts into a National Institute on Drug Abuse-funded project.
- Data collection on HIV risk, service utilization, and implementation barriers.
Main Results:
- Case management did not demonstrate a significant reduction in HIV risk to date.
- Significant barriers to large-scale implementation were identified.
- Barriers included excessive time on basic needs, patient non-participation in support services, and provider reluctance.
Conclusions:
- Enhanced case management, as implemented, did not effectively reduce HIV risk in this population.
- Barriers to patient engagement and provider acceptance impede the scalability of such interventions.
- Further research is needed to optimize case management strategies for substance abuse treatment and HIV prevention.